Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Nanomedicine|December 6, 2019
Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancerSneha Mahalunkar, Amit Singh Yadav, Mahadeo Gorain, et al.
Frontiers in Oncology|October 29, 2021
MiRNA-146a/AKT/β-Catenin Activation Regulates Cancer Stem Cell Phenotype in Oral Squamous Cell Carcinoma by Targeting CD24Sangeeta Ghuwalewala, Dishari Ghatak, Sumit Das, et al.
ACS Omega|January 29, 2024
Poly(d,l-lactide-co-glycolide) Surface-Anchored Biotin-Loaded Irinotecan Nanoparticles for Active Targeting of Colon CancerPrabhanjan S Giram, Ramakrishna Nimma, Anuradha Bulbule, et al.
Journal of Medicinal Chemistry|June 18, 2010
Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migrationJay Prakash Singh, Sudarsan Tamang, P R Rajamohanan, et al.
BMC Cancer|January 10, 2018
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathwayDhiraj Kumar, Saikat Haldar, Mahadeo Gorain, et al.
Cancer & Metabolism|April 17, 2021
Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1Arpankumar Choksi, Apoorva Parulekar, Richa Pant, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 26, 2020
Extracellular volatilomic alterations induced by hypoxia in breast cancer cellsRavindra Taware, Khushman Taunk, Totakura V S Kumar, et al.
Nanomedicine (London, England)|May 16, 2022
Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer modelChaitali Surve, Ananya Banerjee, Anupriya S, et al.
Cancer Biology & Medicine|June 7, 2023
Therapeutic implications of cancer stem cells in prostate cancerPinaki Banerjee, Prachi Kapse, Shehnaz Siddique, et al.
Journal of Biochemical and Molecular Toxicology|January 4, 2021
N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterolShreetama Bandyopadhayaya, Mikhail G Akimov, Ranjeet Verma, et al.
Pageof 10